Correlation between serum total T3 and free T4 levels and heart failure after acute myocardial infarction
-
摘要: 目的:探讨血清总三碘甲状腺氨酸 (T3)、游离甲状腺素 (fT4) 及其比值在预测急性心肌梗死 (AMI) 患者经皮冠状动脉介入术 (PCI) 后继发心力衰竭 (heart failure, HF) 的临床价值。方法:回顾性分析2007-01-2015-12我科收治的404例AMI行急诊PCI患者的一般治疗、行PCI前的血清生化标志物、超声心动图、冠状动脉造影等临床资料, 以及PCI后1年内的心脑血管不良事件的发生情况, 尤其是因HF再入院治疗的发生率, 并根据有无因HF再入院治疗将患者分为HF组和非HF组。通过组间比较、受试者工作特征曲线 (ROC曲线)、logistics回归分析等评估血清总T3、fT4及其比值与HF再入院发生率的相关性。结果:404例AMI患者中, 18例患者 (4.5%) 在PCI治疗后12个月内因HF再次入院治疗。HF组的血清总T3水平低于非HF组[(84.3±21.0) ng/dl:(101.2±20.4) ng/dl, P<0.001], 而fT4水平高于非HF组[(1.44±0.26) ng/dl:(1.23±0.22) ng/dl, P<0.001], 并且HF组的总T3/fT4值低于非HF组 (58.39±21.35:124.54±24.07, P<0.001)。血清总T3水平、总T3/fT4值在ROC曲线下面积分别为0.763和0.795, 其诊断阈值分别为81.19ng/dl和67.46。在多因素logistics回归分析中, 总T3/fT4值降低是AMI患者PCI治疗1年内发生HF的独立预测因子 (OR=0.976, 95%CI:0.9640.989, P<0.001)。结论:AMI后总T3水平的降低与PCI治疗后1年内HF的发生密切相关, 总T3/fT4值<67.46是预测HF发生的良好指标。Abstract: Objective: To investigate the predictive value of serum total T3, free T4 (fT4) and their ratio in the ouccurance of heart failure (HF) after acute myocardial infarction (AMI) treated with percutaneous coronary intervention (PCI).Method: This study retrospectively enrolled 404 cases of AMI patients treated with PCI during January 2007 to December 2015 in our department.The baseline characteristics of serum biochemical markers, echocardiography and coronary angiography results, and 1 year major adverse cardiovascular and cerebrovascular events, especially for HF requiring re-hospitalization, were collected.All patients were subgrouped into HF group and nonHF group based on the occurrence of HF requiring re-hospitalization.The correlation between the total serum T3, fT4 and its ratio and the incidence of HF requiring re-hospitalization statistically analyzed by comparing the groups, the receiver operating characteristic curve, and the logistics regression analysis.Result: Among the 404 patients with AMI, 18 patients (4.5%) were rehospitalized within 12 months to control HF symptoms.The serum total T3 levels in HF group were significantly lower than non-HF group [(84.3±21.0) ng/dl vs (101.2±20.4) ng/dl, P<0.001], the fT4 levels were higher than that of non-HF group [(1.44±0.26) ng/dl vs (1.23±0.22) ng/dl, P<0.001], and the total T3/fT4 ratio in HF group were lower than that of non-HF patients (58.39±21.35 vs 124.54±24.07, P<0.001).The area under ROC curve for serum total T3 level and the total T3/fT4 ratio were 0.763 and 0.795 respectively, and the diagnostic thresholds were 81.19 ng/dl and 67.46 for total T3 level and the total T3/fT4 respectively.In the multivariate logistic regression analysis, the lower total T3/fT4 ratio was an independent predictor of HF requiring re-hospitalization within a year of AMI patients after PCI treatment (OR=0.976, 95%CI:0.964~0.989, P<0.001).Conclusion: The decrease of total T3 levels after AMI were well correlated with 1 year HF in patients treated with PCI, and the total T3/fT4 ratio<67.46 was a good index for predicting the occurrence of HF.
-
Key words:
- acute myocardial infarction /
- heart failure /
- serum total T3 /
- free T4 /
- total T3/fT4 ratio
-
-
[1] Klein I, Ojamaa K.Thyroid hormone and the cardiovascular system[J].N Engl J Med, 2001, 344 (7):501-509.
[2] Klein I, Danzi S.Thyroid disease and the heart[J].Circulation, 2007, 116 (15):1725-1735.
[3] Friberg L, Drvota V, Bjelak AH, et al.Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction[J].Am J Med, 2001, 111 (9):699-703.
[4] Mancini A, Di Segni C, Raimondo S, et al.Thyroid Hormones, Oxidative Stress, and Inflammation[J].Mediators Inflamm, 2016, 2016 (1):6757154.
[5] Iervasi G, Pingitore A, Landi P, et al.Low-T3 syndrome a strong prognostic predictor of death in patients with heart disease[J].Circulation, 2003, 107 (5):708-713.
[6] 薛增明, 杨彦立, 安巨会, 等.甲状腺激素对急性ST段抬高型心肌梗死合并急性心力衰竭患者预后的研究[J].心肺血管病杂志, 2015, 34 (7):533-536.
[7] Zhang B, Peng W, Wang C, et al.A low fT3 level as a prognostic marker in patients with acute myocardial infarctions[J].Intern Med, 2012, 51 (21):3009-3015.
[8] Levine GN, Bates ER, Blankenship JC, et al.2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With STElevation Myocardial Infarction:An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J].Circulation, 2016, 133 (11):1135-1147.
[9] de Vries EM, Fliers E, Boelen A.The molecular basis of the non-thyroidal illness syndrome[J].J Endocrinol, 2015, 225 (3):R67-R81.
[10] Senthil S, Irwin K, Sara D, et al.Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction[J].Am J Cardiol, 2012, 110 (2):234-239.
[11] Lymvaios I, Mourouzis I, Cokkinos DV, et al.Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction:a strong association?[J].Eur J Endocrinol, 2011, 165 (1):107-114.
[12] Liu Y, Sherer BA, Redetzke RA, et al.Regulation of arteriolar density in adult myocardium during low thyroid conditions[J].Vascul Pharmacol, 2010, 52 (3-4):146-150.
[13] Ojamaa K, Kenessey A, Shenoy R, et al.Thyroid hor mone metabolism and cardiac gene expression after acute myocardial infarction in the rat[J].Am J Physiol Endocrinol Metab, 2000, 279 (6):E1319-E1324.
[14] Olivares EL, Marassi MP, Fortunato RS, et al.Thyroid function disturbance and type 3iodothyronine deiodinase induction after myocardial infarction in rats a time course study[J].Endocrinology, 2007, 148 (10):4786-4792.
-
计量
- 文章访问数: 161
- PDF下载数: 89
- 施引文献: 0